Position in EXEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$599,812,735
+$38,136,409 QoQ
Shares Held
11,023,943
-15.8% QoQ
Ownership
4.45%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#5
of 739 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $5,646,694,420 across 216 Biotechnology names. EXEL ranks #3 (10.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,126,080 | $702,155,918 | |
| 2 | INCY |
Incyte Corp
|
5,320,901 | $603,177,333 | |
| 3 | EXEL |
Exelixis, Inc.
This page
|
11,023,943 | $599,812,735 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,522,568 | $366,893,205 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
5,699,541 | $326,127,732 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
616,170 | $306,070,117 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,295,450 | $242,611,869 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,305,412 | $241,404,446 |
All Filings in EXEL
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $599,812,738 | 11,023,943 | Shares | Sole | 2026-08-12 | |
| 2026-06-30 | $599,812,735 | 11,023,943 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $561,676,326 | 13,095,741 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $598,647,140 | 13,658,388 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $379,190,124 | 9,181,359 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $335,275,959 | 7,606,079 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $254,522,380 | 6,893,889 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $132,101,265 | 3,967,005 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $81,902,039 | 3,156,148 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $73,737,056 | 3,281,578 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $69,087,023 | 2,911,379 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $52,267,132 | 2,178,705 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $44,046,060 | 2,015,838 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $36,339,020 | 1,901,571 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $45,368,934 | 2,337,400 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $42,130,712 | 2,626,603 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $26,688,975 | 1,702,103 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $40,905,449 | 1,964,719 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $19,848,718 | 875,550 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $8,654,172 | 473,423 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,208,585 | 293,689 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,493,716 | 136,867 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $8,149,975 | 360,778 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $25,287,778 | 1,259,979 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $53,744,718 | 2,198,148 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $85,043,778 | 3,582,299 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $95,708,828 | 5,558,004 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||